Genetic susceptibility to Behcet's disease: role of genes belonging to the MHC region.

OBJECTIVE To review the progress in the field of MHC-related genetic susceptibility to Behçet's disease (BD). METHOD Systematic review of the English literature between 1 January 1980 and 31 January 2010 using Medline. Case-control, population-based, observational cohort studies investigating the association between BD and HLA-B*51 subtypes, classical and non-classical HLA alleles and other HLA-related genes were selected. The geographical distribution of BD and these susceptibility genes was also taken into consideration. Case and familial case reports were excluded except for case series with more than two patients. RESULTS Ninety articles plus 17 obtained from other sources were included in the systematic review. We have found high evidence that a core component of genetic susceptibility to BD is within the MHC region being primarily related to an HLA-B*51 subtype: HLA-B*5101/B*510101. Moreover, HLA-A*26, HLA-B*15, HLA-B*5701 and TNF-α -1031C were independently associated with BD. Data suggest that other HLA (HLA-C, HLA-DR) and HLA-related [MHC Class I chain-related gene A (MIC-A), TNF-α] genes may play a role in BD co-susceptibility or pathogenesis. Finally, the distinctive geographical distribution of BD suggested an evolutionary selection of HLA-B*51 subtypes as the major susceptibility factors for BD. CONCLUSION Further studies must be addressed to clarify the functional relevance of the different genes found to be associated with disease susceptibility and the potential interactions between genes located within and outside the MHC region.

[1]  Yoonosuke Watanabe,et al.  Behcet's Disease , 2019, Definitions.

[2]  N. Zhai,et al.  Study on association between polymorphism of HLA‐DRB1 alleles and Behçet's disease , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  L. Guillevin,et al.  HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. , 2009, Arthritis and rheumatism.

[4]  S. Dastgiri,et al.  TNF-α gene polymorphisms in Iranian Azeri Turkish patients with Behcet’s Disease , 2009, Rheumatology International.

[5]  H. Inoko,et al.  Genetics of Behçet disease inside and outside the MHC , 2009, Annals of the rheumatic diseases.

[6]  G. Wallace Novel genetic analysis in Behçet's disease , 2009, Arthritis research & therapy.

[7]  S. Gabriel,et al.  Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study. , 2009, Arthritis and rheumatism.

[8]  Beth Cobb,et al.  Identification of novel genetic susceptibility loci for Behçet's disease using a genome-wide association study , 2009, Arthritis research & therapy.

[9]  H. Oral,et al.  Cytokine gene polymorphisms in Behçet's disease and their association with clinical and laboratory findings. , 2009, Clinical and experimental rheumatology.

[10]  S. Tsai,et al.  A genetic study of Behçet's disease in Taiwan Chinese. , 2008, Tissue antigens.

[11]  H. Inoko,et al.  Re-evaluation of heterogeneity in HLA-B*510101 associated with Behçet's disease. , 2008, Tissue antigens.

[12]  D. Mendonça,et al.  New insights of HLA class I association to Behçet's disease in Portuguese patients. , 2008, Tissue antigens.

[13]  B. Yalçın,et al.  The functional role of nuclear factor kappa‐κB1 −94 ins/del ATTG promotor gene polymorphism in Behçet’s disease: an exploratory study , 2008, Clinical and experimental dermatology.

[14]  R. Vonthein,et al.  IL-6 receptor, IL-8 receptor and TNF-alpha238 (G/A) polymorphisms are not associated with Behçet's disease in patients of German or Turkish origin. , 2008, Clinical and experimental rheumatology.

[15]  C. Farra,et al.  TNF polymorphisms in Lebanese patients with Behçet's disease. , 2008, Clinical and experimental rheumatology.

[16]  Bjoern Peters,et al.  HLA class I supertypes: a revised and updated classification , 2008, BMC Immunology.

[17]  I. Tohnai,et al.  Association of Major Histocompatibility Complex Class I Chain-Related Gene A and HLA-B Alleles with Behçet's Disease in Turkey , 2007, Japanese Journal of Ophthalmology.

[18]  S. Sohn,et al.  Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease. , 2007, Tissue antigens.

[19]  M. Houman,et al.  Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet's disease. , 2007, Human immunology.

[20]  A. Fraser,et al.  Prevalence and clinical aspects of Behcet’s disease in the north of Israel , 2007, Clinical Rheumatology.

[21]  I. Olivieri,et al.  Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. , 2007, Arthritis and rheumatism.

[22]  S. Sohn,et al.  HLA-E*0101 and HLA-G*010101 reduce the risk of Behcet's disease. , 2007, Tissue antigens.

[23]  Y. Bek,et al.  T helper 1 type cytokines polymorphisms: association with susceptibility to Behçet’s disease , 2007, Clinical Rheumatology.

[24]  W. Jang,et al.  The novel –G646A polymorphism of the TNFα promoter is associated with the HLA‐B51 allele in Korean patients with Behçet's disease , 2007, Scandinavian journal of rheumatology.

[25]  H. Direskeneli Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder? , 2006, Rheumatology.

[26]  H. Gollnick,et al.  Prevalence of Adamantiades-Behçet's disease in Germany and the municipality of Berlin: results of a nationwide survey. , 2006, Clinical and experimental rheumatology.

[27]  D. Bang,et al.  Increased risk of human leukocyte antigen-G gene variants in Behçet's disease. , 2006, Clinical and experimental rheumatology.

[28]  Nayoung Kim,et al.  Association of TNFA Promoter Region Haplotype in Behçet's Disease , 2006, Journal of Korean medical science.

[29]  E. Alpsoy,et al.  TNF‐α gene 1031 T/C polymorphism in Turkish patients with Behçet's disease , 2006 .

[30]  G. Espinosa,et al.  Allelic Diversity and Affinity Variants of MICA are Imbalanced in Spanish Patients with Behçet's Disease , 2006, Scandinavian journal of immunology.

[31]  Jerzy K. Kulski,et al.  Four-digit allele genotyping of the HLA-A and HLA-B genes in Japanese patients with Behcet's disease by a PCR-SSOP-Luminex method. , 2006, Tissue antigens.

[32]  K. Nakae,et al.  Microsatellite polymorphisms of the MICA gene among Japanese patients with Behçet's disease. , 2006, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[33]  M. Duman,et al.  Lack of association of tumor necrosis factor-alpha gene polymorphisms with disease susceptibility and severity in Behçet’s disease , 2006, Rheumatology International.

[34]  R. Vaughan,et al.  Associations of major histocompatibility complex class I chain-related molecule polymorphisms with Behcet's disease in Caucasian patients. , 2005, Tissue antigens.

[35]  K. Kim,et al.  Interleukin-18 gene polymorphisms in Korean patients with Behçet's disease. , 2005, Clinical and experimental rheumatology.

[36]  A. Silman,et al.  Whole-genome screening for susceptibility genes in multicase families with Behçet's disease. , 2005, Arthritis and rheumatism.

[37]  H. Inoko,et al.  Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's disease. , 2004, Arthritis and rheumatism.

[38]  C. Aliaǧaoǧlu,et al.  HLA class I and class II genotyping in patients with Behcet's disease: a regional study of eastern part of Turkey. , 2004, Tissue antigens.

[39]  Ö. Pamuk,et al.  Prevalence of Behçet's disease in rural western Turkey: a preliminary report. , 2004, Clinical and experimental rheumatology.

[40]  H. Nagafuchi,et al.  Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behçet's disease , 2004, Rheumatology International.

[41]  E. Soto-Vega,et al.  Class I and class II MHC polymorphisms in Mexican patients with Behçet's disease. , 2004, Immunology letters.

[42]  J. Kalil,et al.  MICA polymorphism in a sample of the São Paulo population, Brazil. , 2004, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[43]  A. Gül,et al.  Prevalence of Behçet's disease in Istanbul, Turkey , 2003, International journal of dermatology.

[44]  J. Daurès,et al.  Identification of an autosomal recessive mode of inheritance in paediatric Behçet's families by segregation analysis , 2003, American journal of medical genetics. Part A.

[45]  U. Ozbek,et al.  Tumour necrosis factor-alpha gene promoter region -308 and -376 G-->A polymorphisms in Behçet's disease. , 2003, Clinical and experimental rheumatology.

[46]  M. Stanford,et al.  Behçet’s disease in patients of west African and Afro-Caribbean origin , 2003, The British journal of ophthalmology.

[47]  E. Lee,et al.  TNF and TNF receptor polymorphisms in Korean Behcet's disease patients. , 2003, Human immunology.

[48]  F. Takeuchi,et al.  Association of Transporter Associated with Antigen Processing Genes with Behçet's Disease in Japanese , 2003, Autoimmunity.

[49]  T. Ahmad,et al.  Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms? , 2003, Arthritis and rheumatism.

[50]  H. Inoko,et al.  Analysis of microsatellite polymorphism around the HLA-B locus in Iranian patients with Behçet's disease. , 2002, Tissue antigens.

[51]  R. Ravazzolo,et al.  MICA gene polymorphisms in an Italian paediatric series of juvenile Behçet disease. , 2002, International journal of molecular medicine.

[52]  J. Barrett,et al.  A weak association of HLA-B*2702 with Behçet’s disease , 2002, Genes and Immunity.

[53]  Kyung-Su Park,et al.  Association of MICA polymorphism with HLA-B51 and disease severity in Korean patients with Behcet's disease. , 2002, Journal of Korean medical science.

[54]  Lutfi Jaber,et al.  Prevalence of Behçet's disease in an Arab community in Israel , 2002, Annals of the rheumatic diseases.

[55]  H. Inoko,et al.  Sequencing-based typing of HLA-B*51 alleles and the significant association of HLA-B*5101 and -B*5108 with Behçet's disease in Greek patients. , 2002, Tissue antigens.

[56]  S. Metzger,et al.  Association of the MIC-A gene and HLA-B51 with Behçet's disease in Arabs and non-Ashkenazi Jews in Israel , 2002, Annals of the rheumatic diseases.

[57]  F. Spertini,et al.  Behçet’s disease in Western Switzerland: Epidemiology and analysis of ocular involvement , 2002, Ocular immunology and inflammation.

[58]  H. Direskeneli Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51 , 2001, Annals of the rheumatic diseases.

[59]  Y. Molad,et al.  Allelic distribution of HLA-B*5 in HLA-B5-positive Israeli patients with Behçet's disease. , 2001, Tissue antigens.

[60]  H. Inoko,et al.  HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Behçet's disease. , 2001, Tissue antigens.

[61]  C. Zouboulis,et al.  Comparative analysis of the association of HLA-B*51 suballeles with Behçet's disease in patients of German and Turkish origin. , 2001, Tissue antigens.

[62]  I. Olivieri,et al.  Association of MICA alleles and HLA-B51 in Italian patients with Behçet's disease. , 2001, The Journal of rheumatology.

[63]  H. Inoko,et al.  Microsatellite mapping of a susceptible locus within the HLA region for Behçet's disease using Jordanian patients. , 2001, Human immunology.

[64]  S. Caillat-Zucman,et al.  HLA-B*51 and B*15 alleles confer predisposition to Behçet's disease in Moroccan patients. , 2001, Human immunology.

[65]  H. Inoko,et al.  Localization of the pathogenic gene of Behçet's disease by microsatellite analysis of three different populations. , 2000, Investigative ophthalmology & visual science.

[66]  H. Inoko,et al.  Significant associations of HLA-B*5101 and B*5108, and lack of association of class II alleles with Behçet's disease in Italian patients. , 1999, Tissue antigens.

[67]  Gen Tamiya,et al.  Complete sequence and gene map of a human major histocompatibility complex , 1999 .

[68]  H. Inoko,et al.  Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease. , 1999, Arthritis and rheumatism.

[69]  S. Ohno,et al.  Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. , 1999, Tissue antigens.

[70]  R. Vaughan,et al.  HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease. , 1999, Tissue antigens.

[71]  H. Inoko,et al.  HLA class I and II typing of the patients with Behçet's disease in Saudi Arabia. , 1999, Tissue antigens.

[72]  J. Sánchez-Román,et al.  Lack of association of MICA transmembrane region polymorphism and Behçet's disease in Spain. , 1999, Tissue antigens.

[73]  H. Inoko,et al.  Association of MICA gene and HLA-B*5101 with Behçet's disease in Greece. , 1999, Investigative ophthalmology & visual science.

[74]  I. Touitou,et al.  Familial aggregation in Behçet's disease: high frequency in siblings and parents of pediatric probands. , 1999, The Journal of pediatrics.

[75]  Nobuhisa Mizuki,et al.  MIC-A allele profiles and HLA class I associations in Behçet's disease , 1999, Immunogenetics.

[76]  H. Inoko,et al.  The critical region for Behçet disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping. , 1999, American journal of human genetics.

[77]  G. Tamiya,et al.  Microsatellite polymorphism within the MICB gene among Japanese patients with Behçet's disease. , 1998, Human immunology.

[78]  J. Sánchez-Román,et al.  Association of HLA-B51 subtypes and Behçet's disease in Spain. , 1998, Tissue antigens.

[79]  M. Spyropoulou,et al.  HLA-B*5101 in Greek patients with Behçet's disease. , 1998, Human immunology.

[80]  E. Alpsoy,et al.  HLA Antigens and Linkage Disequilibrium Patterns in Turkish Behçet's Patients , 1998, The Journal of dermatology.

[81]  H. Gollnick,et al.  Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. , 1997, Yonsei medical journal.

[82]  H. Inoko,et al.  A strong association between HLA-B*5101 and Behçet's disease in Greek patients. , 1997, Tissue antigens.

[83]  R. Lawrence,et al.  Class I HLA antigens in spondyloarthropathy: observations in Alaskan Eskimo patients and controls. , 1997, The Journal of rheumatology.

[84]  M. Yamazaki,et al.  Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[85]  S. Ohno,et al.  LMP7 polymorphism in Japanese patients with sarcoidosis and Behçet's disease. , 1996, Human immunology.

[86]  H. Inoko,et al.  HLA-C genotyping of patient with Behçet's disease in the Japanese population. , 1996, Human immunology.

[87]  J. Sanderson,et al.  Role of γδ T cells in pathogenesis and diagnosis of Behçet's disease , 1996, The Lancet.

[88]  T. Shiina,et al.  Allelic variations in the TAP2 and LMP2 genes in Behçet's disease. , 1996, Tissue antigens.

[89]  H. Direskeneli,et al.  Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. , 1996, Annals of the rheumatic diseases.

[90]  N. Sayınalp,et al.  Cytokines in Behçet's disease. , 1996, The Journal of rheumatology.

[91]  S. Ohno,et al.  Microsatellite polymorphism between the tumor necrosis factor and HLA-B genes in Behçet's disease. , 1995, Human immunology.

[92]  V. Gnau,et al.  Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behćet's disease. , 1995, International immunology.

[93]  W. Jacyk Behçet's disease in South African blacks: report of five cases. , 1994, Journal of the American Academy of Dermatology.

[94]  H. Inoko,et al.  Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101. , 1993, American journal of ophthalmology.

[95]  E. Hedfors,et al.  Behçet's disease: a review and a report of 12 cases from Sweden. , 1993, Acta dermato-venereologica.

[96]  C. Chiang,et al.  HLA-DR and DQ antigens in Chinese patients with Behçet's disease. , 1993, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[97]  S. Ohno,et al.  Human leukocyte antigen serologic and DNA typing of Behçet's disease and its primary association with B51. , 1992, Investigative ophthalmology & visual science.

[98]  H. Inoko,et al.  RFLP analysis in the TNF-beta gene and the susceptibility to alloreactive NK cells in Behçet's disease. , 1992, Investigative ophthalmology & visual science.

[99]  X. Jian,et al.  Histocompatibility antigens associated with Behçet's disease in northern Han Chinese. , 1992, Internal medicine.

[100]  I. Crombie,et al.  Behçet's syndrome in Scotland. , 1992, Postgraduate medical journal.

[101]  K. Hoshi,et al.  Increased peripheral blood gamma delta+ T cells and natural killer cells in Behçet's disease. , 1992, The Journal of rheumatology.

[102]  M. Rubini,et al.  Serological and molecular HLA typing in Italian Behçet's patients: significant association to B51-DR5-DQw3 haplotype. , 1992, Tissue antigens.

[103]  Z. Meiner,et al.  Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome. , 1991, Annals of the rheumatic diseases.

[104]  Denis Wakefield,et al.  Behset's syndrome: ocular features in an Australian population , 1990 .

[105]  A. Al-Dalaan,et al.  BEHÇET'S DISEASE IN SAUDI ARABIA. , 1989 .

[106]  K. Ayed,et al.  Behçet's disease and major histocompatibility complex class II antigens in Tunisians. , 1988, Disease markers.

[107]  K. Sharquie,et al.  Behçet's disease in Iraqi patients. , 1986, Annals of the rheumatic diseases.

[108]  L. Melchiorri,et al.  Behcet's disease associated with HLA-B51 and DRw52 antigens in Italians. , 1986, Human immunology.

[109]  Moore Sb,et al.  Lack of association between Behçet's disease and major histocompatibility complex class II antigens in an ethnically diverse North American Caucasoid patient group. , 1986 .

[110]  H. Matsuda,et al.  Close association of HLA-Bw51 with Behçet's disease. , 1982, Archives of ophthalmology.

[111]  B. Schwartz,et al.  A public antigenic determinant in the HLA-B5 cross-reacting group--a basis for cross-reactivity and a possible link with Behcet's disease. , 1980, Human immunology.

[112]  S. Ohno,et al.  HLA-Bw51 and Behçet's disease. , 1978, JAMA.

[113]  M. Chamberlain Behcet's syndrome in 32 patients in Yorkshire. , 1977, Annals of the rheumatic diseases.

[114]  E. Alpsoy,et al.  TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease. , 2006, The British journal of dermatology.

[115]  J. Sánchez-Román,et al.  TAP polymorphism in patients with Behet'fs disease , 2004 .

[116]  D Middleton,et al.  New allele frequency database: http://www.allelefrequencies.net. , 2003, Tissue antigens.

[117]  A. Silman,et al.  Evidence for linkage of the HLA-B locus in Behçet's disease, obtained using the transmission disequilibrium test. , 2001, Arthritis and rheumatism.

[118]  Young Keun Kim,et al.  Copyright � The Korean Academy of Medical Sciences Epidemiologic and Clinical Survey of Behcet's Disease in Korea: the First Multicenter Study , 2001 .

[119]  Elena S. Babaylova,et al.  Complete sequence and gene map of a human major histocompatibility complex , 1999, Nature.

[120]  C. Vilches,et al.  HLA-Cw*1602: a new susceptibility marker of Behçet's disease in southern Spain. , 1998, Tissue antigens.

[121]  N. Yamashita,et al.  Hyperreactivity of neutrophils and abnormal T cell homeostasis: a new insight for pathogenesis of Behçet's disease. , 1997, International reviews of immunology.

[122]  T. Lehner,et al.  Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. , 1996, Lancet.

[123]  H. Yazıcı,et al.  The prevalence of Behçet's syndrome in a rural area in northern Turkey. , 1988, The Journal of rheumatology.

[124]  S. Moore,et al.  Lack of association between Behçet's disease and major histocompatibility complex class II antigens in an ethnically diverse North American Caucasoid patient group. , 1986, The Journal of rheumatology.